North America Ablation Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The North America Ablation Devices Market is segmented by Type, Application (General Surgery, Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmological Treatment, Gynecological Treatment, Urological Treatment, Cosmetic Surgery, and Others), End User and Geography.

Market Snapshot

North America Ablation Technologies Market
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 8.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The North America Ablation Devices Market is expected to register a CAGR of nearly 8.5 % during the forecast period. Rising incidences of diseases such as cancer and cardiac ailments are expected to boost the demand for ablation procedures. The technological advancements to design high-end products and growing demand for treatment procedures, which are minimally invasive are also expected to boost the ablation technologies market. 

Furthermore, the rising number of the ageing population having a higher risk of target diseases is another vital factor driving the demand for ablation procedures.

According to the Canadian Cancer Statistics 2019 report, it is estimated that nearly 1 in 2 Canadians will be diagnosed with cancer in their lifetime. An estimated 220,400 new cases of cancer are diagnosed in Canada in 2019. The number of cases in males (113,000) was expected to be slightly higher than in females (107,400).

Therefore, the rising prevalence of cancer and other chronic diseases is expected to show significant growth over the forecast period. However, stringent regulatory framework leading to an increase in the gestation period for product launches is also a market challenge which is hindering the market growth.

Scope of the report

As per the scope of the report, ablation generally refers to the removal of a part of biological tissue, usually by surgery. Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers. The North America Ablation Devices market is segmented by technology, application, end-User, and geography.

By Device Technology
Radiofrequency Devices
Laser/Light Ablation
Ultrasound Devices
Cryoablation Devices
Other Devices
By Application
Cancer Treatment
Cardiovascular Disease Treatment
Ophthalmologic Treatment
Gynecological Treatment
Urological Treatment
Cosmetic Surgery
Other Applications
By End-Users
Ambulatory Surgical Centers
Other End-Users
North America
United States

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cancer Treatment Segment is Expected to Hold Significant Market Share in the North America Ablation Devices Market

According to the estimates of the American Cancer Society,  in 2018, there were about 1,735,350 new cancer cases diagnosed and 609,640 deaths, due to cancer in the United States. The most common cancers in the United States are breast cancer, lung cancer, prostate cancer, colorectum cancer, bladder cancer, and skin cancer.

North America has a better healthcare infrastructure, as compared to other regions around the world. The increasing spending on research and development on cancer treatment is expected to drive the market in North America. The National Cancer Institute (NCI) has stated that the national spending on cancer care is expected to reach USD 156 billion, by 2020 in the United States.

Thus, owing to the rising R&D, increasing prevalence of cancer, and the presence of better healthcare infrastructure in North America, the market is expected to witness a high growth rate over the forecast period.

NA ablation key trend 1.png

Competitive Landscape

The North America Ablation Devices market is moderately competitive and consists of a few major players. Companies like Abbott, AngioDynamics, Inc., AtriCure, Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson and Johnson, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC, among others, hold the substantial market share in the Ablation Devices market.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Prevalence of Chronic Diseases

      2. 4.2.2 Emergence of Next-generation Ablation Products and Technology

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Device and Stringent Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Device Technology

      1. 5.1.1 Radiofrequency Devices

      2. 5.1.2 Laser/Light Ablation

      3. 5.1.3 Ultrasound Devices

      4. 5.1.4 Cryoablation Devices

      5. 5.1.5 Other Devices

    2. 5.2 By Application

      1. 5.2.1 Cancer Treatment

      2. 5.2.2 Cardiovascular Disease Treatment

      3. 5.2.3 Ophthalmologic Treatment

      4. 5.2.4 Gynecological Treatment

      5. 5.2.5 Urological Treatment

      6. 5.2.6 Cosmetic Surgery

      7. 5.2.7 Other Applications

    3. 5.3 By End-Users

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End-Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 AngioDynamics, Inc.

      3. 6.1.3 AtriCure, Inc.

      4. 6.1.4 Boston Scientific Corporation

      5. 6.1.5 BTG plc

      6. 6.1.6 Conmed Corporation

      7. 6.1.7 Johnson and Johnson

      8. 6.1.8 Medtronic PLC

      9. 6.1.9 Olympus Corporation

      10. 6.1.10 Smith & Nephew PLC

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The North America Ablation Devices Market market is studied from 2018 - 2026.

The North America Ablation Devices Market is growing at a CAGR of 8.5% over the next 5 years.

Abbott Laboratories, Boston Scientific Corporation, Johnson and Johnson (Biosense Webster, Inc), Medtronic PLC, AngioDynamics, Inc are the major companies operating in North America Ablation Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!